Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00200122 · ClinicalTrials.gov registry record · Phase 4

Restore Claims Characterization Study

A Phase 4 study of Chronic Refractory Pain Associated With Failed Back Surgery Syndrome, Epidural Fibrosis, Peripheral Causalgia, Complex Regional Pain Syndrome, sponsored by MedtronicNeuro.

Completed
Registry status
Phase 4
Development phase
100
Enrollment target
8
Study locations

NCT00200122 is a Phase 4 study of Chronic Refractory Pain Associated With Failed Back Surgery Syndrome, Epidural Fibrosis, Peripheral Causalgia, Complex Regional Pain Syndrome that has completed, run by MedtronicNeuro. The registered enrollment target is 100 participants. The trial reports 8 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00200122, a Phase 4 study of Chronic Refractory Pain Associated With Failed Back Surgery Syndrome, Epidural Fibrosis, Peripheral Causalgia, Complex Regional Pain Syndrome, has completed, sponsored by MedtronicNeuro.

COMPLETED
Registry status
Phase 4
Development phase
100 participants
Enrollment target
8
Study locations

Study Summary

The purpose of this study is to characterize the pain coverage capability of the RESTORE spinal cord stimulation (SCS) and assess health outcomes.

Interventions

  • DEVICE Spinal Cord Stimulation

Study Locations (8)

Texas

  • Contact Medtronic for Exact Location - Dallas
  • Contact Medtronic for Exact Location - San Antonio

Illinois

  • Contact Medtronic for Exact Location - Chicago

Indiana

  • Contact Medtronic for Exact Location - Indianapolis

Missouri

  • Contact Medtronic for Exact Location - Kansas City

New York

  • Contact Medtronic for Exact Location - Syosset

Oregon

  • Contact Medtronic for Exact Location - Eugene

West Virginia

  • Contact Medtronic for Exact Location - Huntington

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2005-01
Est. Completion 2007-08
Phase Phase 4

Sponsor

MedtronicNeuro

51 total trials

What the Registry Record Tells You About NCT00200122

The ClinicalTrials.gov registry entry for NCT00200122 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MedtronicNeuro, which has 51 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Chronic Refractory Pain Associated With Failed Back Surgery Syndrome, Epidural Fibrosis, Peripheral Causalgia, Complex Regional Pain Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Spinal Cord Stimulation is the first listed.

NCT00200122 reports 8 study locations spanning 7 distinct geographic areas - top geographies include Texas, Illinois, Indiana.

Frequently Asked Questions

What is clinical trial NCT00200122 about?

NCT00200122 is a clinical study titled "Restore Claims Characterization Study". The purpose of this study is to characterize the pain coverage capability of the RESTORE spinal cord stimulation (SCS) and assess health outcomes.

What is the current status of trial NCT00200122?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2005-01. Estimated completion is 2007-08.

What conditions does trial NCT00200122 study?

This clinical trial studies the following conditions: Chronic Refractory Pain Associated With Failed Back Surgery Syndrome, Epidural Fibrosis, Peripheral Causalgia, Complex Regional Pain Syndrome.

What interventions are being tested in trial NCT00200122?

The interventions under investigation include: Spinal Cord Stimulation (DEVICE).

Who is sponsoring clinical trial NCT00200122?

This trial is sponsored by MedtronicNeuro, which has 51 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00200122 being conducted?

This trial has 8 study locations across Illinois, Indiana, Missouri, New York, Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.